We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSRA
301
DELISTED
CSRA Inc.
CSRA
| $25.1M | 0.03% |
786,982
+8,313
| +1% | +$243K |
|
302
Huron Consulting
HURN
$1.82B
| $25M | 0.03% |
494,387
+3,729
| +0.8% | +$199K |
|
303
Maximus
MMS
$3.14B
| $24.9M | 0.03% |
446,424
+1,829
| +0.4% | +$99.4K |
|
304
Nu Skin
NUS
$247M
| $24.9M | 0.03% |
520,683
-224
| -0% | -$12.5K |
|
305
Granite Construction
GVA
$5.45B
| $24.7M | 0.03% |
449,303
-211,563
| -32% | -$11.2M |
|
306
Booking.com
BKNG
$138B
| $24.1M | 0.03% |
411,475
+175
| +0% | +$10.5K |
|
|
SIVB
307
DELISTED
SVB Financial Group
SIVB
| $24M | 0.03% |
139,924
-8,929
| -6% | -$1.28M |
|
308
FTI Consulting
FCN
$4.82B
| $24M | 0.03% |
531,322
+5,774
| +1% | +$251K |
|
|
AEGN
309
DELISTED
Aegion Corp
AEGN
| $23.9M | 0.03% |
1,009,403
+2,827
| +0.3% | +$62.7K |
|
310
Customers Bancorp
CUBI
$2.59B
| $23.7M | 0.03% |
660,730
-184,320
| -22% | -$5.44M |
|
311
Hanmi Financial
HAFC
$943M
| $23.6M | 0.03% |
676,211
-635
| -0.1% | -$18.5K |
|
|
LBY
312
DELISTED
Libbey, Inc.
LBY
| $23.3M | 0.03% |
1,195,143
-53,640
| -4% | -$968K |
|
|
CELG
313
DELISTED
Celgene Corp
CELG
| $22.8M | 0.03% |
197,320
+7,762
| +4% | +$864K |
|
314
MPLX
MPLX
$59.5B
| $22.8M | 0.03% |
+658,947
| New | +$21.4M |
|
315
Teradyne
TER
$54.8B
| $22.6M | 0.03% |
891,513
-7,562
| -0.8% | -$179K |
|
316
Blackstone Mortgage Trust
BXMT
$2.82B
| $22.5M | 0.03% |
748,244
+409,236
| +121% | +$12.2M |
|
|
CLDT
317
Chatham Lodging
CLDT
$630M
| $22.5M | 0.03% |
1,092,906
-5,219
| -0.5% | -$100K |
|
318
Columbia Banking Systems
COLB
$8.81B
| $22.4M | 0.03% |
501,331
-144
| -0% | -$5.43K |
|
|
ACH
319
Accendra Health
ACH
$240M
| $22.3M | 0.03% |
631,612
+1,712
| +0.3% | +$57.9K |
|
320
NETGEAR
NTGR
$669M
| $22M | 0.03% |
404,352
+5,218
| +1% | +$279K |
|
321
Packaging Corp of America
PKG
$22.7B
| $21.7M | 0.03% |
255,293
-1,865,061
| -88% | -$156M |
|
|
EQC
322
DELISTED
Equity Commonwealth
EQC
| $21.5M | 0.03% |
712,070
+145,670
| +26% | +$4.31M |
|
|
OB
323
DELISTED
Onebeacon Insurance Group Ltd
OB
| $21.3M | 0.03% |
1,328,755
-13,510
| -1% | -$204K |
|
|
CLNY
324
DELISTED
Colony Capital, Inc.
CLNY
| $21.3M | 0.03% |
1,052,994
+329,408
| +46% | +$6.45M |
|
|
LHO
325
DELISTED
LaSalle Hotel Properties
LHO
| $21.2M | 0.03% |
696,355
-4,057
| -0.6% | -$109K |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.